Skip to main content
Skip to main content
DOCS logo

Doximity, Inc. (DOCS) Stock Analysis

$25.98 +$0.225 (+0.87%) |Exceptional · 94
Doximity, Inc. (DOCS) bottom line: signals are mixed — the Council read leans Bullish Lean (72/100) while the AI fundamental score is 94/100 (grade A+); the two lenses disagree, so weigh the breakdown below. Strongest single signal: Moon AI bullish.
MCap: $4.86B| P/E Ratio: 19.6| Vol: 1.34M| Target: $46.16 (+77.7%)| 52-wk range: $17.15 – $76.51
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Doximity, Inc. (DOCS) trades at $25.98 with AI Score 94/100 (Grade A+). Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. Market cap: $4.86B, Sector: Healthcare.

Price as of Aug 20, 2026 · Last analyzed: May 9, 2026
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company provides tools for collaboration, patient care coordination, virtual visits, medical news access, and career management.

DOCS stock analysis for 2026: Analysts have set a consensus price target of $46.16 for Doximity, Inc., suggesting 77.7% upside from the current price of $25.98. The AI MoonshotScore is 94/100, indicating a strong bullish outlook. Key factors: analyst coverage, AI-driven quantitative scoring.

Watch the DOCS film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Bullish Lean 72/100 · A

DOCS: 2/3 scored disciplines lean bullish. Dominant signal: Moon AI bullish.

How is this calculated? →
MoonshotScore · Growth Potential · 94/100
Business Quality
Strong Is this a genuinely good business?
Financial Safety
Strong Could this blow up on me?
Valuation
Moderate Am I paying a fair price?
Growth Durability
Strong Is the growth real and likely to last?
Momentum
Weak Is the market already moving on this?
Legends Council · 5 Legends + Moon AI
Ken Griffin
Bullish
Izzy Englander
Neutral
Seth Klarman
Bullish
Moon AI
Bullish
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Moderate
Margin of Safety
Undervalued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →

Why this analysis is different

  • A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
  • An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
  • Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Doximity, Inc. (DOCS) Healthcare & Pipeline Overview

CEOJeffrey A. Tangney
Employees827
HeadquartersSan Francisco, CA, US
IPO Year2021

Doximity, Inc. provides a cloud-based digital platform tailored for medical professionals in the U.S., facilitating collaboration, patient care coordination, and career management. Serving pharmaceutical manufacturers and healthcare systems, Doximity distinguishes itself through specialized tools and a focus on streamlining medical workflows within the healthcare information services sector.

Data Provenance | Financial Data Quantitative Analysis NYSE Analysis: May 9, 2026

What Is the Investment Thesis for DOCS?

As of May 9, 2026 — figures reflect the data available on that date.

Doximity, Inc. presents a compelling investment thesis centered on its dominant position within the healthcare information services sector. With a market capitalization of $4.86B and a P/E ratio of 19.6, the company demonstrates strong profitability, supported by a high gross margin of 89.7% and a profit margin of 37.5%. Key value drivers include the increasing adoption of telehealth and virtual care, which fuels demand for Doximity's platform. Growth catalysts include expanding its service offerings to address additional needs within the healthcare ecosystem. Potential risks include increased competition from established technology companies entering the healthcare space and evolving regulatory landscape surrounding data privacy and security.

Based on FMP financials and quantitative analysis

DOCS Key Highlights

Market capitalization of $4.86B reflects investor confidence in Doximity's growth potential.

  • P/E ratio of 19.6 indicates a premium valuation, suggesting strong earnings expectations.
  • Gross margin of 89.7% demonstrates efficient cost management and pricing power.
  • Profit margin of 37.5% highlights the company's ability to generate substantial profits from its revenue.
  • Beta of 1.42 suggests higher volatility compared to the overall market.

Who Are DOCS's Competitors?

DOCS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
EXAS Exact Sciences Corporation $104.91 +0.00% $20.0B 62
VTRS Viatris Inc. $16.25 +0.46% $18.9B 31
COO The Cooper Companies, Inc. $76.74 +0.01% $15.0B 77
GH Guardant Health, Inc. $163.34 +2.01% $21.9B 33
SOLV Solventum Corporation $88.98 +1.33% $15.4B 56
HNGE Hinge Health, Inc. $88.46 +0.25% $6.85B 95
ONEM ONEM $16.47 +0.00% $3.40B 55
HQY HealthEquity, Inc. $103.95 +1.13% $8.69B 90

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are DOCS's Key Strengths?

Dominant position in the medical professional networking space.

  • High gross and profit margins.
  • Strong brand recognition and reputation.
  • Large and engaged user base.

What Are DOCS's Weaknesses?

Reliance on advertising revenue.

  • Potential for increased competition.
  • Dependence on the U.S. healthcare market.
  • Vulnerability to data breaches and privacy concerns.

What Could Drive DOCS Stock Higher?

DOCS catalyst: Potential partnerships with major healthcare systems to integrate Doximity's platform into their workflows by Q4 2026.

  • Increasing adoption of telehealth services driving demand for Doximity's virtual visit capabilities.
  • Expansion of Doximity's platform to include new features and functionalities, such as AI-powered clinical decision support tools.
  • Launch of new advertising campaigns targeting specific medical specialties in Q3 2026.

What Are the Key Risks for DOCS?

Increased competition from established technology companies entering the healthcare space.

  • Evolving regulatory landscape surrounding data privacy and security could impact Doximity's operations.
  • Dependence on advertising revenue makes Doximity vulnerable to economic downturns and changes in marketing budgets.
  • Data breaches and privacy concerns could damage Doximity's reputation and erode user trust.

What Are the Growth Opportunities for DOCS?

  • Expansion into new specialties and subspecialties represents a significant growth opportunity for Doximity. By tailoring its platform to meet the specific needs of different medical disciplines, Doximity can attract new users and increase engagement. The market size for specialized healthcare platforms is estimated to be substantial, with potential for significant revenue growth over the next 3-5 years.
  • Increasing adoption of telehealth and virtual care creates opportunities for Doximity to expand its virtual visit capabilities and integrate with telehealth platforms. As telehealth becomes more mainstream, Doximity can capitalize on the growing demand for virtual care solutions.
  • Development of new features and functionalities, such as AI-powered tools for clinical decision support, can enhance the value proposition of Doximity's platform and attract new users. By leveraging artificial intelligence and machine learning, Doximity can provide medical professionals with valuable insights and improve patient outcomes. The market for AI in healthcare is rapidly expanding, presenting a significant growth opportunity.
  • Strategic partnerships with healthcare systems and pharmaceutical companies can expand Doximity's reach and accelerate adoption of its platform. By collaborating with key players in the healthcare ecosystem, Doximity can gain access to new markets and customers. Strategic partnerships can also provide Doximity with valuable data and insights, enabling it to further improve its platform.
  • International expansion represents a long-term growth opportunity for Doximity. By expanding its platform to other countries, Doximity can tap into new markets and diversify its revenue streams. The global market for healthcare information services is substantial, with significant growth potential in emerging markets. International expansion would require Doximity to adapt its platform to meet the specific needs of different healthcare systems and regulatory environments.

What Threats Does DOCS Face?

  • Evolving regulatory landscape surrounding data privacy and security.
  • Disruption from new technologies and business models.
  • Economic downturn and reduced healthcare spending.
  • Negative publicity or reputational damage.

What Are DOCS's Competitive Advantages?

  • Network effect: The value of the platform increases as more medical professionals join and engage with it.
  • Data advantage: Doximity has access to a vast amount of data on medical professionals and their interactions, which can be used to improve its platform and services.
  • Brand recognition: Doximity is a well-known and respected brand among medical professionals.
  • Switching costs: Medical professionals who rely on Doximity's platform for communication and collaboration are unlikely to switch to a competitor.

What Does DOCS Do?

Doximity, Inc., initially incorporated as 3MD Communications, Inc. in 2010 before rebranding, is a cloud-based digital platform catering to medical professionals in the United States. Founded in 2010 and headquartered in San Francisco, California, the company's core mission is to equip medical practitioners with tools that enhance collaboration, streamline patient care coordination, facilitate virtual patient visits, provide access to the latest medical news and research, and support career management. Doximity's platform serves as a central hub where medical professionals can connect with colleagues, securely share patient information, and engage in continuous medical education. The company primarily serves pharmaceutical manufacturers and healthcare systems, offering targeted advertising and communication solutions. Doximity's evolution reflects the increasing digitization of healthcare and the need for efficient communication and information sharing among medical professionals. Its platform has become an integral part of the daily workflow for many physicians and healthcare providers, solidifying its position in the healthcare information services sector.

What Products and Services Does DOCS Offer?

  • Provides a cloud-based digital platform for medical professionals.
  • Enables collaboration among medical colleagues.
  • Facilitates coordination of patient care.
  • Conducts virtual patient visits.
  • Provides access to the latest medical news and research.
  • Helps medical professionals manage their careers.
  • Offers targeted advertising and communication solutions for pharmaceutical manufacturers.

How Does DOCS Make Money?

  • Subscription fees from medical professionals for premium features and services.
  • Advertising revenue from pharmaceutical manufacturers and healthcare systems.
  • Data analytics and insights services for healthcare organizations.
  • Sponsorships and partnerships with industry events and organizations.

What Industry Does DOCS Operate In?

Doximity, Inc. operates within the rapidly evolving healthcare information services sector. The industry is characterized by increasing digitization, driven by the need for improved efficiency, better patient outcomes, and reduced costs. The market is competitive, with established players and emerging startups vying for market share. Doximity differentiates itself through its focus on medical professionals and its comprehensive platform that addresses multiple needs, including communication, collaboration, and career management. The healthcare information services market is projected to continue growing, fueled by factors such as the aging population, increasing prevalence of chronic diseases, and advancements in technology.

Who Are DOCS's Key Customers?

  • Medical professionals, including physicians, nurses, and other healthcare providers.
  • Pharmaceutical manufacturers seeking to reach and engage with medical professionals.
  • Healthcare systems looking to improve communication and collaboration among their staff.
  • Recruiting firms seeking to hire medical professionals.
AI Confidence: 73% Updated: May 9, 2026

Doximity, Inc. Financial Trajectory

Doximity, Inc. (DOCS) reported $156.6M in revenue for Q2 2026, reflecting 7.7% growth compared to the prior quarter. The company recorded net income of $24.3M, with diluted EPS of $0.13. Quarter-over-quarter revenue has been mixed, typical for a mid-cap company operating in Healthcare. Across the four most recent quarters, DOCS averaged $0.21 in diluted EPS.

Company Profile

Doximity, Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in San Francisco, US. The company is led by CEO Jeffrey A. Tangney. DOCS has traded publicly since 2021.

How Doximity, Inc. Is Valued

Doximity, Inc. carries a market capitalization of $4.86B, placing it in the mid-cap category. Relative to its peer group, DOCS's quantitative score of 94/100 is above the peer average of 52/100.

ROE 19%

Key Financial Metrics

Return on equity for Doximity, Inc. stands at 19.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 17.4%, showing how much profit it generates from its asset base. DOCS trades at a trailing price-to-earnings ratio of 19.56, below the Healthcare sector average of ~23x. Its free cash flow yield is 8.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 6.09 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 5.1%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 6/9

Financial Health

Doximity, Inc.'s Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 19.21 places it in the safe zone, indicating low near-term bankruptcy risk.

6/8 beats

Earnings Track Record

Doximity, Inc. has beaten Wall Street's EPS estimate in 6 of its last 8 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 17.0% above estimates on average.

FY2026 est

Forward Outlook

Wall Street analysts project Doximity, Inc. revenue of about $643.6M for fiscal 2026, with EPS near $1.55. The estimate reflects 17 contributing analysts.

Net buying

Insider Activity

Over the past six months, Doximity, Inc. insiders filed 27 SEC Form 4 transactions — 14 sales and 13 purchases. On net that is roughly 3.0M shares acquired (about $71.8M) — insiders putting money in tends to read as conviction.

DOCS Financials

Fundamental Snapshot

Revenue Growth (FY)
+13.1%
Net Income Growth (FY)
-12.2%
EPS Growth (FY)
-11.8%
Free Cash Flow Growth (FY)
+19.0%
P/E (TTM)
19.6
Return on Equity (TTM)
+19.4%
Current Ratio
6.1
EV/EBITDA (TTM)
13.8

Based on FMP financials and quantitative analysis · FY 2026

Bull Case vs Bear Case

Bull Case

  • Doximity's recent insider buying activity indicates strong confidence from leadership in the company's future.
  • Community sentiment has been notably positive, with discussions highlighting the platform's user growth among healthcare professionals.
  • The recent expansion into new services has attracted attention, suggesting potential for increased revenue streams.
  • Analysts have noted the company's strong position in the telehealth market, which continues to gain traction post-pandemic.

Bear Case

  • Concerns have been raised about the competitive landscape, with new entrants potentially threatening Doximity's market share.
  • Recent community discussions reflect skepticism regarding the sustainability of user growth amid changing healthcare dynamics.
  • Some investors are wary of potential regulatory challenges that could impact Doximity's operations and profitability.
  • Market perception remains cautious, as some analysts question the company's valuation relative to its growth prospects.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q2 2026 $157M $24M $0.13
Q1 2026 $145M $19M $0.10
Q4 2025 $185M $62M $0.31
Q3 2025 $169M $62M $0.31

Based on FMP financials and quantitative analysis

DOCS Latest News

DOCS Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for DOCS.

Price Targets

Consensus target: $46.16

DOCS MoonshotScore

94/100

What does this score mean?

The MoonshotScore rates DOCS 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.

Leadership: Jeffrey A. Tangney

CEO

Jeffrey A. Tangney is the Chief Executive Officer of Doximity, Inc. He has extensive experience in the healthcare technology industry. Prior to Doximity, Tangney co-founded Epocrates, a leading provider of mobile drug reference tools for healthcare professionals. He holds a Bachelor of Science degree in Electrical Engineering from the University of Michigan and an MBA from Stanford University. Tangney's leadership has been instrumental in driving Doximity's growth and success.

Track Record: Under Jeffrey Tangney's leadership, Doximity has achieved significant milestones, including its successful IPO and expansion into new markets and service offerings. He has overseen the development of innovative features and functionalities that have enhanced the value proposition of Doximity's platform. Tangney has also fostered a strong company culture focused on innovation and customer satisfaction.

Doximity, Inc. Healthcare Stock: Key Questions Answered

What does the AI Score mean for DOCS?

DOCS holds an AI Score of 94/100 (Grade: A+). This is an educational research signal, not a buy or sell recommendation. Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company provides tools for collaboration, patient care coordination, virtual visits …

What does Doximity, Inc. do?

Doximity, Inc. operates a cloud-based digital platform designed specifically for medical professionals in the United States. The platform provides a suite of tools that facilitate collaboration among colleagues, coordinate patient care, conduct virtual patient visits, access the latest medical news and research, and manage their careers.

What do analysts say about DOCS stock?

Analyst consensus on DOCS stock is mixed, with some highlighting the company's strong growth potential and dominant position in the medical professional networking space. Key valuation metrics, such as the P/E ratio, suggest a premium valuation, reflecting high expectations for future earnings growth. However, analysts also caution about potential risks, including increased competition and evolving regulatory landscape.

What are the main risks for DOCS?

Doximity, Inc. faces several key risks, including increased competition from established technology companies and emerging startups vying for market share in the healthcare information services sector. Evolving regulations surrounding data privacy and security could also impact Doximity's operations and increase compliance costs. Additionally, the company's reliance on advertising revenue makes it vulnerable to economic downturns and changes in marketing budgets.

What are the key factors to evaluate for DOCS?

Doximity, Inc. (DOCS) holds an AI score of 94/100 (high). P/E: 19.6x vs the S&P 500's ~20-25x. Analysts target $46.16 (+78%). Not financial advice.

How frequently does DOCS data refresh on this page?

DOCS's price was last updated on Aug 20, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven DOCS's recent stock price performance?

Doximity, Inc. (DOCS) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Dominant position in the medical professional networking space. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider DOCS overvalued or undervalued right now?

Doximity, Inc. (DOCS) trades at 19.6x earnings. Analysts target $46.16 (+78%) — upside seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

How do I research DOCS before investing?

Before investing in Doximity, Inc. (DOCS), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on available data and may be subject to change.
  • Financial metrics are as of the latest reporting period.
Data Sources

Popular Stocks

More Stocks We Cover